Solid Biosciences Inc.: director Ilan Ganot received 150,000 shares

What happened Ilan Ganot, director, received 150,000 restricted stock units (RSUs) as an award on Oct 1, 2026. The filing reports a per-unit price of $0.00 and a total reported value of $0.00; the transaction is reported as a derivative award (code A).

Key details

• Transaction date and price: Oct 1, 2026; 150,000 RSUs at $0.00 (derivative, code A).
• Shares owned after the transaction: the Form 4 does not report shares owned after the transaction.
• Footnotes: F1 — each RSU represents a contingent right to receive one share of common stock; F2 — the RSUs were granted on Oct 1, 2026 and vest in full on Oct 1, 2029, subject to continued service through the vesting date.
• Filing date and timeliness: the Form 4 was filed on Oct 26, 2026; the filing indicates late (transactionTimeliness = 'L').

Why it may matter

• This was an award of RSUs, not a market purchase or sale.
• The RSUs vest in full on Oct 1, 2029 subject to continued service.
• The filing does not show why the insider traded or why the company acted.